SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001104659-20-115697
Filing Date
2020-10-16
Accepted
2020-10-16 17:24:47
Documents
42

Document Format Files

Seq Description Document Type Size
1 S-1 tm2030088-7_s1.htm S-1 2970189
2 EXHIBIT 3.1 tm2030088d8_ex3-1.htm EX-3.1 160512
3 EXHIBIT 3.3 tm2030088d8_ex3-3.htm EX-3.3 163391
4 EXHIBIT 4.2 tm2030088d8_ex4-2.htm EX-4.2 287462
5 EXHIBIT 4.3 tm2030088d8_ex4-3.htm EX-4.3 84093
6 EXHIBIT 10.2 tm2030088d8_ex10-2.htm EX-10.2 165385
7 EXHIBIT 10.3 tm2030088d8_ex10-3.htm EX-10.3 86686
8 EXHIBIT 10.8 tm2030088d8_ex10-8.htm EX-10.8 199174
9 EXHIBIT 10.9 tm2030088d8_ex10-9.htm EX-10.9 17864
10 EXHIBIT 10.10 tm2030088d8_ex10-10.htm EX-10.10 16806
11 EXHIBIT 10.11 tm2030088d8_ex10-11.htm EX-10.11 13357
12 EXHIBIT 10.12 tm2030088d8_ex10-12.htm EX-10.12 18183
13 EXHIBIT 10.13 tm2030088d8_ex10-13.htm EX-10.13 308742
14 EXHIBIT 10.14 tm2030088d8_ex10-14.htm EX-10.14 25426
15 EXHIBIT 10.15 tm2030088d8_ex10-15.htm EX-10.15 21146
16 EXHIBIT 10.16 tm2030088d8_ex10-16.htm EX-10.16 40528
17 EXHIBIT 10.17 tm2030088d8_ex10-17.htm EX-10.17 24516
18 EXHIBIT 10.18 tm2030088d8_ex10-18.htm EX-10.18 46488
19 EXHIBIT 10.19 tm2030088d8_ex10-19.htm EX-10.19 28816
20 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM tm2030088d8_ex23-1.htm EX-23.1 2135
21 GRAPHIC lg_in8bio-4c.jpg GRAPHIC 4393
22 GRAPHIC tm2030088d1-fc_enetic4c.jpg GRAPHIC 288370
23 GRAPHIC tm2030088d1-fc_improbw.jpg GRAPHIC 137479
24 GRAPHIC tm2030088d1-fc_inb4c.jpg GRAPHIC 256759
25 GRAPHIC tm2030088d1-fc_project4c.jpg GRAPHIC 495621
26 GRAPHIC tm2030088d1-lc_fig12bw.jpg GRAPHIC 108703
27 GRAPHIC tm2030088d1-lc_improbw.jpg GRAPHIC 1271496
28 GRAPHIC tm2030088d1-lc_mgmt4c.jpg GRAPHIC 135163
29 GRAPHIC tm2030088d1-ph_cells4c.jpg GRAPHIC 274085
30 GRAPHIC tm2030088d1-ph_cranial4c.jpg GRAPHIC 234960
31 GRAPHIC tm2030088d1-ph_hsctcon4c.jpg GRAPHIC 167656
32 GRAPHIC tm2030088d1-ph_immune4c.jpg GRAPHIC 352985
33 GRAPHIC tm2030088d1-ph_inpadm4c.jpg GRAPHIC 314854
34 GRAPHIC tm2030088d1-ph_inppha4c.jpg GRAPHIC 242555
35 GRAPHIC tm2030088d1-ph_mainten4c.jpg GRAPHIC 299442
36 GRAPHIC tm2030088d1-ph_shortfal4c.jpg GRAPHIC 326981
37 GRAPHIC tm2030088d1-ph_tarcells4c.jpg GRAPHIC 248716
38 GRAPHIC tm2030088d1-ph_tumorcel4c.jpg GRAPHIC 191223
39 GRAPHIC tm2030088d1-tb_treatmbw.jpg GRAPHIC 364421
40 GRAPHIC tm2030088d2ex10-13img01.jpg GRAPHIC 8753
41 GRAPHIC tm2030088d5_ex10-19img001.jpg GRAPHIC 13306
42 GRAPHIC tm2030088d7-fc_devel4c.jpg GRAPHIC 1132117
  Complete submission text file 0001104659-20-115697.txt   13836701
Mailing Address 79 MADISON AVENUE, 2ND FLOOR NEW YORK NY 10016
Business Address 79 MADISON AVENUE, 2ND FLOOR NEW YORK NY 10016 (646) 600-6438
IN8BIO, INC. (Filer) CIK: 0001740279 (see all company filings)

IRS No.: 825462585 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-249530 | Film No.: 201244723
SIC: 2836 Biological Products, (No Diagnostic Substances)